EGFR and skin squamous cell carcinoma: Systemic therapy in cSCC was until recently limited to cytotoxic chemotherapeutic regimens or EGFR inhibitors.7,23–29 However, with the development of immune checkpoint inhibitors new promising treatment options have opened up for this disease.